Two days of debate over the safety of paclitaxel-coated and -eluting devices have culminated in a nonbinding recommendation by the FDA to continue sales of such devices for PAD patients, though the agency is also urging regulators to push for better long-term clinical data than is currently available.

After years of limited success, researchers have found a way to convert type A blood cells into the more universal type O by leveraging human gut bacteria, according to a report in the magazine Science.

Canadian researchers have singled out a peptide known as apelin that could improve survival in CV patients with aortic aneurysms, leading them to dub the molecule the equivalent of insulin for heart disease.

A Wisconsin high schooler is speaking up for stroke awareness after she suffered a stroke of her own during gym class, WAOW reported—an event her doctors said was brought on by her birth control pills.

Arizona-based R3 Stem Cell, LLC is under fire this week after the FDA sent the company an untitled, three-page letter detailing significant shortcomings in their process.

People who take popular heartburn drugs like Prevacid, Prilosec and Nexium are vulnerable to death from cardiovascular disease, chronic kidney disease and upper gastrointestinal cancer, according to new research published in The BMJ.

Smoking flavored e-cigarettes can have a detrimental effect on endothelial function, leaving e-cig users prone to poor vascular health and heart disease, researchers report in the June edition of the Journal of the American College of Cardiology.

The popular anticoagulant dabigatran is no more effective than aspirin when it comes to preventing recurrent stroke in patients with a history of embolic events, researchers reported in the New England Journal of Medicine May 16.

Researchers have linked a specific type of immune cell found in arterial plaque to increased probability of a stroke or mini-stroke.  

Fragmin (dalteparin sodium), a type of heparin that works as an anticoagulant, was approved by the FDA May 16 to treat symptomatic venous thromboembolism (VTE) in pediatric patients aged one month and up.

A dietary supplement commonly used to relieve osteoarthritis and joint pain may also double as a cardioprotector, Tulane University researchers reported in The BMJ May 14.

Low-dose daily aspirin may be effective as a preventive therapy for heart patients with symptomatic atherosclerotic disease, but in the general population the drug’s risk of intracranial bleeding outweighs any CV benefits it may have, according to a study published May 13 in JAMA Neurology.